How China Became the Biotech Industry’s Back-Office

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

China's Atomic Energy Law, taking effect Thursday, is set to boost high-quality development of nuclear power: expert

A view of the Experimental Advanced Superconducting Tokamak (EAST), dubbed China's "artificial sun," in Hefei, East China's ...
Nature

China leads research in 90% of crucial technologies — a dramatic shift this century

China is leading research in nearly 90% of the crucial technologies that “significantly enhance, or pose risks to, a country’s national interests”, according to a technology tracker run by the ...
CNBC

It's not just AI — China's quickly gaining an edge over the U.S. in biotech

Out of five critical tech sectors, "China has the most immediate opportunity to overtake the United States in biotechnology," the Harvard Belfer Center said in a new report. Just as China is ...
The Diplomat

When Will China Begin Earning Nobel Prizes in Science?

China’s rise in science has been even more dramatic than its rapid economic development. China and the United States currently spend far more on research and development and publish significantly more ...
The Diplomat

China’s Development Strategy in the 15th Five-Year Plan Era

The recently concluded Fourth Plenum Session of the Communist Party of China approved the draft proposal for the 15th Five-Year Plan, setting the strategic direction for China’s next stage of ...
FierceBiotech

China proposes shorter clinical trial reviews in efforts to accelerate drug development

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...